HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thor Ueland Selected Research

Interleukin-6 Receptors (Interleukin 6 Receptor)

1/2021Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction.
1/2021Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
1/2019Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI).
1/2019Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction.
11/2018Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction.
1/2018IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
1/2018Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction.
10/2017Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction.
8/2016Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
1/2014Anakinra and tocilizumab enhance survival and function of human islets during culture: implications for clinical islet transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thor Ueland Research Topics

Disease

110Inflammation (Inflammations)
11/2022 - 11/2002
69Heart Failure
04/2022 - 11/2002
40Myocardial Infarction
12/2020 - 03/2004
27Atherosclerosis
10/2020 - 07/2002
24Acute Coronary Syndrome
10/2021 - 07/2002
19Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 07/2002
17Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 05/2006
16Schizophrenia (Dementia Praecox)
01/2022 - 11/2009
13Fibrosis (Cirrhosis)
11/2022 - 12/2006
13ST Elevation Myocardial Infarction
06/2022 - 05/2009
12Infections
10/2022 - 03/2003
12Mental Disorders (Mental Disorder)
01/2022 - 11/2009
12Stroke (Strokes)
06/2020 - 03/2011
12Insulin Resistance
01/2017 - 05/2006
11Pneumonia (Pneumonitis)
10/2022 - 01/2016
10Venous Thromboembolism
04/2022 - 12/2018
10Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 02/2010
10HIV Infections (HIV Infection)
11/2020 - 04/2003
10Atherosclerotic Plaque (Atheroma)
10/2019 - 07/2002
9Infarction (Infarctions)
01/2021 - 03/2004
9Acromegaly
12/2019 - 03/2005
8Non-ST Elevated Myocardial Infarction
01/2021 - 08/2016
8Aortic Valve Stenosis (Aortic Stenosis)
01/2021 - 08/2011
8Bipolar Disorder (Manic Depressive Psychosis)
01/2020 - 11/2009
7Type 2 Diabetes Mellitus (MODY)
11/2022 - 07/2012
7Obesity
04/2022 - 09/2009
7Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2021 - 01/2003
7Necrosis
10/2019 - 11/2004
7Gestational Diabetes (Gestational Diabetes Mellitus)
01/2019 - 07/2015
7Disease Progression
01/2018 - 04/2003
7Diabetes Mellitus
01/2018 - 05/2006
6Thrombosis (Thrombus)
05/2022 - 04/2006
6Respiratory Insufficiency (Respiratory Failure)
05/2022 - 03/2012
6Left Ventricular Dysfunction
01/2022 - 05/2005
6Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 04/2013
6Pre-Eclampsia (Preeclampsia)
11/2021 - 01/2002
6Malaria
10/2021 - 01/2014
6Neoplasms (Cancer)
01/2020 - 11/2004
6Stable Angina
01/2011 - 07/2002
5Systemic Scleroderma (Systemic Sclerosis)
01/2022 - 08/2015
5Hypertension (High Blood Pressure)
12/2021 - 11/2002
5Coinfection
10/2021 - 01/2014
5Falciparum Malaria (Plasmodium falciparum Malaria)
10/2021 - 01/2014
5Hypertrophy
04/2021 - 01/2005

Drug/Important Bio-Agent (IBA)

58Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2007
49CytokinesIBA
04/2022 - 03/2003
37C-Reactive ProteinIBA
12/2021 - 04/2006
27Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
25Interleukin-6 (Interleukin 6)IBA
06/2022 - 03/2003
25OsteoprotegerinIBA
12/2018 - 07/2002
24Troponin T (Troponin T1)IBA
06/2022 - 11/2009
23Glucose (Dextrose)FDA LinkGeneric
11/2022 - 05/2006
18Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 03/2004
18ChemokinesIBA
01/2019 - 07/2002
17Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 11/2002
17pro-brain natriuretic peptide (1-76)IBA
01/2022 - 05/2007
16Messenger RNA (mRNA)IBA
08/2020 - 07/2002
15Rosuvastatin Calcium (Crestor)FDA Link
11/2019 - 03/2011
14LigandsIBA
01/2022 - 07/2004
14Interleukin-8 (Interleukin 8)IBA
01/2017 - 03/2002
13LipidsIBA
01/2022 - 10/2005
13Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2018 - 08/2009
12tocilizumab (atlizumab)FDA Link
06/2022 - 01/2014
12von Willebrand FactorIBA
12/2021 - 04/2006
11Complement System Proteins (Complement)IBA
01/2021 - 01/2002
10Trinitrotoluene (TNT)IBA
06/2022 - 06/2011
10Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2021 - 01/2014
10EnzymesIBA
02/2020 - 01/2009
10Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2019 - 01/2003
9Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2016 - 11/2009
8Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
10/2019 - 04/2003
8AdipokinesIBA
01/2019 - 07/2009
8CD40 Ligand (CD40L)IBA
02/2015 - 01/2003
8activin AIBA
01/2015 - 03/2004
8Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2014 - 07/2002
8RANK LigandIBA
06/2010 - 07/2002
7InterleukinsIBA
06/2022 - 06/2012
7Interleukin-18 (Interleukin 18)IBA
01/2022 - 03/2002
7AdiponectinIBA
01/2021 - 05/2006
7Insulin-Like Growth Factor I (IGF-1)IBA
12/2019 - 03/2003
7Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2018 - 08/2009
7Insulin (Novolin)FDA Link
01/2018 - 12/2009
6Ferritins (Ferritin)IBA
05/2022 - 01/2018
6IronIBA
04/2022 - 01/2018
6CholesterolIBA
01/2022 - 07/2009
6Vitamin DFDA LinkGeneric
01/2020 - 01/2015
6CalciumIBA
02/2016 - 03/2003
6Matrix Metalloproteinases (MMPs)IBA
01/2014 - 05/2005
5Pharmaceutical PreparationsIBA
11/2022 - 11/2005
5Galectin 3 (LGALS3)IBA
11/2022 - 08/2011
5Growth Differentiation Factor 15IBA
04/2022 - 01/2019
5LeptinIBA
04/2022 - 01/2010
5Cytokine Receptor gp130IBA
01/2022 - 01/2013
5Lipopolysaccharide ReceptorsIBA
01/2021 - 11/2014
5InterferonsIBA
01/2021 - 05/2010
5Chemotactic FactorsIBA
12/2020 - 04/2006
5Indicators and Reagents (Reagents)IBA
06/2020 - 03/2003

Therapy/Procedure

24Therapeutics
10/2021 - 01/2003
10Percutaneous Coronary Intervention
04/2021 - 06/2008
5Kidney Transplantation
01/2022 - 05/2006